Exploring the complexities of prostate cancer screening with a view to supporting informed consent

References

• Abbas K & Oakeshott (2002): Pilot study of testicular cancer awareness and testicular self examination in men attending two south London general practices. Family Practice 19(3): 294–296.
   Google Scholar
• Algood CB, Newell GR, Johnson DE (1988): Viral etiology of testicular tumors. Journal of Urology 139: 308–310.
   Google Scholar
• Anti Cancer Foundation, South Australia (1998): Prostate cancer: should I be tested, Mr. PHIP pamphlet series (Prostate Health Improvement Program) February.
   Google Scholar
• Australian Institute of Health and Welfare (AIHW) & Australasian Association of Cancer Registries (ACCR) (2003) Cancer in Australia, AIHW cat. No. 18, Canberra: AIHW (cancer series number 23).
   Google Scholar
• Basso D, Fogar P, Piva MG, Navaglia F, Mazza S, Prayer-Galetti T, Castellucci E, Pagano F, Plebani M (2000): Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: which is clinically effective and when? Urology 55(5): 710–5.
   Google Scholar
• Carbone S (2002): Prostate test under fire in study. The Age, July 4, page 3.
   Google Scholar
• Chapple A, Ziebland, Sheppard S, Miller R, Herxheimer A, McPherson A (2002): Why men with prostate cancer want wider access to prostate specific testing: qualitative study. British Medical Journal 325(7354): 737–741.
   Google Scholar
• Commonwealth Department of Health and Family Services, Prostate cancer screening: questions and answers. Leaflet with no date, Australia.
   Google Scholar
• Frydenberg M (2002): The PSA testing debate. The Healthy Male: News Letter of Andrology Australia 4: 1.
   Google Scholar
• Gottlieb S (2003): Sigmoidoscopy screening every five years may be too frequent. British Medical Journal 326(7396): 949.
   Google Scholar
• Girgis S, Ward J, Thomson C (1999): General practitioners’ perceptions of medicolegal risk: using case scenarios to assess the potential impact of prostate cancer screening guidelines. The Medical Journal of Australia 171, 4 October, 362–366.
   Google Scholar
• Henry RY & O’Mahony D (1999): Treatment of prostate cancer. Journal of clinical Pharmacy and Therapeutics 24: 93–102.
   Google Scholar
• Hirst G, Ward J, & Del Mar C (1996): Prostate cancer screening: the case against. Medical Journal of Australia 164: 285–287.
   Google Scholar
• Hulbert GM (2000): Medical malpractice: elevated PSA: failure to ensure further follow up for urological exam. Prostate cancer: defense verdict. Michael and Jacqueline Kafka v Steven Seizer, MD and Santa Monica Family Physicians.
   Google Scholar
• Kalish LA, McKinlay JB (1999): Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age-specific reference ranges for total PSA, free PSA, and percent free PSA. Urology 54(6): 1022–7.
   Google Scholar
• Kao CH (1997): Age-related free PSA, total PSA and free PSA/total PSA ratios: establishment of reference ranges in Chinese males. Anticancer Research 17(2B): 1361–5.
   Google Scholar
• Laws TA, Drummond M, Polijak-Flijak J (2000): On what basis do Australian men make informed decisions about diagnostic and treatment options for prostate cancer? Australian Journal of Primary Health – Interchange 6(2): 86–93.
   Google Scholar
• Makinen T, Tammela TLJ, Stenman U, Maattanen L, Rannikko S, Aro J, Juusela H, Hakama M, Auvinen A (2002): Family history and prostate cancer screening with prostate specific antigen. Journal of Clinical Oncology 20(11): 2658–63.
   Google Scholar
• Mayor S (2003): Mammography screening nearly halves breast cancer mortality. British Medical Journal 326(7396): 949.
   Google Scholar
• Mc Credie M Cox B (1998) Prostate-specific antigen testing for prostate cancer: the case for informed consent, Medical Journal of Australia 1998; 169: 9–10.
   Google Scholar
• Perkins JJ, Sanson-Fisher RW, Clarke SJ, Youman P (1998): An exploration of screening practices fro prostate cancer and the associated community expenditure. British Journal of Urology 82: 524–529.
   Google Scholar
• Pinnock CB, O’Brien B, Marshall VR (1998a): Older men’s concerns about their urological health: a qualitative study. Australian and New Zealand Journal of Public Health 22(3): 368–373.
   Google Scholar
• Pinnock CB, Weller DP, Marshall VR (1998b): Self-reported prevalence of prostate-specific antigen testing in South Australia: a community study. Medical Journal of Australia 1998; 169: 25–28.
   Google Scholar
• Raffle AE, Alden B, Quinn M, Babb PJ, Brett MT (2002): Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modeling of cases and deaths prevented. British Medical Journal 326(7395): 901–904.
   Google Scholar
• Risbridger GP (2002): Improving PSA testing. The Healthy Male: News Letter of Andrology Australia 4: 6.
   Google Scholar
• Selvin T, Donnelly N. Clarkson J, English D, Ward E (1999): Prostatic cancer testing: behaviour , motivation and attitudes among Western Australian men. The Medical Journal of Australia 171, 16 August, 185–188.
   Google Scholar
• Sladden M, Dickinson J, (1993): Effectiveness of screening for prostate cancer. Australian Family Physician 22(8): 1385–1392.
   Google Scholar
• Tanguay S, Begin LR, Elhilali MM, Behlouli H, Karakiewicz PI, Aprikian AG (2000): Comparative evaluation of total PSA, free/total PSA, and complexed PSA in prostate cancer detection. Urology 59(2): 261–5.
   Google Scholar
• Ward J, Young J, Sladden M (1998): Australian general practitioners’ views and use of tests to detect early prostate cancer. Australian and New Zealand Journal of Public Health 22: 374–380.
   Google Scholar
• Ward J, Girgis S (1998): ‘Making an ‘informed decision’ about prostate cancer screening: What information is required?’ Health Promotion Journal of Australia 8(3): 173–176.
   Google Scholar
• Weller D, Pinnock C, Silagy C, Hiller JE, Marshall VR (1998): Prostate cancer testing in SA men: influence of sociodemographic factors, health beliefs and LUTS. Australian & New Zealand Journal of Public Health 22(3 Suppl): 400–2.
   Google Scholar